fazarabine
Term · Oncology and biomedicine · MLC-T-ONC-003145
An anticancer drug that is a type of antimetabolite.
An orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action to cytarabine, fazarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; its incorporation into DNA inhibits DNA synthesis, resulting in tumor cell death and tumor necrosis. The presence of deoxycytidine kinase in a tumor is a determinant of tumor sensitivity to this drug.
| Identifier | MLC-T-ONC-003145 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ARA-AC |
| Synonyms | Kymarabine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-003145",
"term": "fazarabine",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that is a type of antimetabolite.",
"An orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action to cytarabine, fazarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; its incorporation into DNA inhibits DNA synthesis, resulting in tumor cell death and tumor necrosis. The presence of deoxycytidine kinase in a tumor is a determinant of tumor sensitivity to this drug."
],
"abbreviation": "ARA-AC",
"synonyms": [
"Kymarabine"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fazarabine/"
}
Record 7,175 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.